Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.53 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.53 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.52 |
| ▸ | CCR3 | P51677 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | BACE1 | P56817 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6749089 | 0.98 | ACHE (0.55) | ACHEMEN1KMT2ATSHRABL1 | |
| Hydrochloric Acid SCHEMBL311655 | 0.98 | ACHE (0.55) | ACHEMEN1KMT2ATSHRABL1 | |
| SCHEMBL2794872 | 0.82 | ALDH1A1 (0.63) | MEN1KMT2ATSHRABL1RIN1 | |
| SCHEMBL1135840 | 0.80 | MEN1 (0.57) | ACHEMEN1KMT2ATSHRABL1 | |
| Hydrochloric Acid SCHEMBL9536512 | 0.78 | CXCR4 (0.59) | ACHECXCR4CCR3BCHEBACE1 | |
| Hydrochloric Acid SCHEMBL310978 | 0.78 | MEN1 (0.56) | ACHEMEN1KMT2ATSHRABL1 | |
| SCHEMBL1717074 | 0.77 | LTA4H (0.63) | MEN1KMT2ATSHRABL1RIN1 | |
| SCHEMBL22483452 | 0.77 | MEN1 (0.58) | ACHEMEN1KMT2ATSHRABL1 | |
| SCHEMBL8263431 | 0.77 | LTA4H (0.63) | MEN1KMT2ATSHRABL1RIN1 | |
| SCHEMBL592839 | 0.76 | MEN1 (0.66) | ACHEMEN1KMT2ATSHRABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040092737-A1 | Benzopiperidine derivatives | EISAI CO., LTD. | 2004-05-13 | — | — | US | disclosed |
| US-6518423-B1 | These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and | EISAI CO., LTD. (JP) | 2003-02-11 | — | — | US | disclosed |
| EP-0934941-A1 | BENZOPIPERIDINE DERIVATIVES | Eisai Co., Ltd. (JP) | 1999-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092737-A1 | Benzopiperidine derivatives | HLA-DRB1, HRH1, HRH2 | ACHE 2066/4885MEN1 4580/4885KMT2A 3395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.